BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 35744053)

  • 1. 6-Shogaol Ameliorates Liver Inflammation and Fibrosis in Mice on a Methionine- and Choline-Deficient Diet by Inhibiting Oxidative Stress, Cell Death, and Endoplasmic Reticulum Stress.
    Yang AY; Kim K; Kwon HH; Leem J; Song JE
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperpolarized [1-
    Piraquive Agudelo J; Kim Y; Agarwal S; Sriram R; Bok R; Kurhanewicz J; Mattis AN; Maher JJ; von Morze C; Ohliger MA
    Magn Reson Med; 2024 Apr; 91(4):1625-1636. PubMed ID: 38115605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating L-arginine production.
    Kim DY; Park JY; Gee HY
    Exp Mol Med; 2023 Nov; 55(11):2332-2345. PubMed ID: 37907736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin alleviates diet-induced steatohepatitis by targeting multiple cell types in the liver to suppress inflammation and fibrosis.
    Xu L; Li H; Zhang O; Zhang F; Song M; Ma M; Zhao Y; Ding R; Li D; Dong Z; Jin S; Han W; Ding C
    J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36356262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swertiamarin ameliorates diet-induced obesity by promoting adipose tissue browning and oxidative metabolism in preexisting obese mice.
    Zhu Y; Li H; Ma M; Li D; Zhang O; Cai S; Wang Y; Chen D; Jin S; Ding C; Xu L
    Acta Biochim Biophys Sin (Shanghai); 2022 Oct; 55(1):131-142. PubMed ID: 36305727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Adv Nutr; 2015 Nov; 6(6):694-702. PubMed ID: 26567194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deuterium-Reinforced Polyunsaturated Fatty Acids Prevent Diet-Induced Nonalcoholic Steatohepatitis by Reducing Oxidative Stress.
    Li H; Zhang O; Hui C; Huang Y; Shao H; Song M; Gao L; Jin S; Ding C; Xu L
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744053
    [No Abstract]   [Full Text] [Related]  

  • 9. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
    Hu J; Zheng Y; Ying H; Ma H; Li L; Zhao Y
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theabrownin ameliorates liver inflammation, oxidative stress, and fibrosis in MCD diet-fed C57BL/6J mice.
    Zhen Q; Liang Q; Wang H; Zheng Y; Lu Z; Bian C; Zhao X; Guo X
    Front Endocrinol (Lausanne); 2023; 14():1118925. PubMed ID: 36742397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
    Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
    Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
    Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y; Sun X; Chen Y; Deng Y; Qian K
    Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.
    Negi CK; Babica P; Bajard L; Bienertova-Vasku J; Tarantino G
    Metabolism; 2022 Jan; 126():154925. PubMed ID: 34740573
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.